The combination of Padcev and Keytruda delivered a phase 3 win in muscle-invasive bladder cancer. China did not renew the conditional approval for a controversial Alzheimer's disease drug. | The ...

There’s a new twist in the fight against bladder cancer — and it’s delivering game-changing results. In a recent clinical ...